A67S (p.Ala67Ser) variant of GFAP (Glial fibrillary acidic protein)

A67S (p.Ala67Ser) in GFAP (Glial fibrillary acidic protein) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.26 / 1. The record also includes population frequency data and structural context.

A67S (p.Ala67Ser) variant details